Assignee
VNV NEWCO INC
US·3 granted patents·6 pending applications·19 citations·filing 2019–2022
Top patents by PatentIndex Score
9 records- 0191US11129892B1Vaccine compositions comprising endogenous Gag polypeptidesVNV NEWCO INC·Filed 2020·Granted Sep 28, 2021·9 cites·23 claims
- 0290US11447527B2Endogenous Gag-based capsids and uses thereofVNV NEWCO INC·Filed 2021·Granted Sep 20, 2022·5 cites·25 claims
- 0389US11505578B2Endogenous Gag-based capsids and uses thereofVNV NEWCO INC·Filed 2021·Granted Nov 22, 2022·5 cites·19 claims
- 0472US2023312657A1Arc-based capsids and uses thereofVNV NEWCO INC·Filed 2022·Application pending·0 cites
- 0567US2021403907A1Arc-based capsids and uses thereofVNV NEWCO INC·Filed 2021·Application pending·0 cites
- 0667US2022016032A1Arc-based capsids and uses thereofVNV NEWCO INC·Filed 2021·Application pending·0 cites
- 0763US2022088224A1Arc-based capsids and uses thereofVNV NEWCO INC·Filed 2019·Application pending·0 cites
- 0858US2023201337A1Vaccine compositions comprising endogenous gag polypeptidesVNV NEWCO INC·Filed 2021·Application pending·0 cites
- 0955US2024102052A1Pnma2-based capsids and uses thereofVNV NEWCO INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when VNV NEWCO INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →